Comparison of the Effect of Lung-protective Ventilation on Optic Nerve Sheath Diameter in Obese and Non-obese Patients
Comparison of the Effect of Recruitment Maneuver and Individualized Positive End-expiratory Pressure on Optic Nerve Sheath Diameter in Obese and Non-obese Patients Undergoing Laparoscopic Surgery
The gol of this prospective observational study is to evaluate the effect of recruitment maneuvers-employed as part of an intraoperative lung-protective ventilation strategy-and individualized positive end-expiratory pressure (PEEP) on intracranial pressure, as assessed by measuring the optic nerve sheath diameter, in both obese and non-obese patients undergoing laparoscopic surgery.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
상세 설명
Laparoscopy is widely used due to its advantages, such as less blood loss, reduced postoperative pain, and faster recovery. However, pneumoperitoneum increases thoracoabdominal pressure, which decreases venous drainage from the brain and increases cerebral blood flow and intracranial pressure (ICP). The optic nerve sheath diameter (ONSD) measurement via ultrasound is a non-invasive and reliable method for assessing ICP.
The prevalence of obesity has increased substantially over recent decades, accompanied by a growing number of obese patients undergoing laparoscopic surgery. Obesity is associated with increased intra-abdominal pressure, which may contribute to an increase in ONSD. Furthermore, the additional rise in intra-abdominal pressure induced by pneumoperitoneum may exacerbate these effects, potentially placing obese patients at greater risk of alterations in cerebral haemodynamics during laparoscopic procedures.
Atelectasis occurs in roughly 90% of all patients undergoing general anaesthesia and can persist for weeks after operation. Intraoperative lung-protective ventilation has been recommended to reduce postoperative pulmonary complications after abdominal and/or laparoscopic surgery and also in obese patients. Decreasing compliance caused by surgical/ anaesthesia factors (i.e. pneumoperitoneum, positioning, and circuit disconnect) should be treated by appropriate interventions. Individualised PEEP and alveolar recruitment manoeuvres can prevent and reverse alveolar collapse, respectively.
However, the effects of these interventions on cerebral haemodynamics, particularly ICP as assessed indirectly by ONSD measurement, remain insufficiently understood in obese and non-obese patients undergoing laparoscopic surgery.
The gol of this prospective observational study is to evaluate the effect of recruitment maneuvers and individualized PEEP- as part of intraoperative lung-protective ventilation strategy- on intracranial pressure, as assessed by measuring the optic nerve sheath diameter (ONSD), in both obese and non-obese patients undergoing laparoscopic surgery.
연구 유형
연구 유형
등록 (추정된)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 연락처
연구 연락처
- 이름: Gulay Erdogan Kayhan, Prof. Dr.
- 전화번호: 905332560011
- 이메일: drgulayer@yahoo.com
연구 연락처 백업
- 이름: Muhammed Alpaslan Uludag, Research Assistant, MD
- 이메일: muho.78@live.com
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Patients over 25 years of age
- American Soc,ety of Anesthesiology (ASA) status I-III
- Scheduled to undergo laparoscopic abdominal surgery
- With an expected pneumoperitoneum duration of ≥1 hour
Exclusion Criteria:
- Patients with ocular disease
- Patients who have undergone cranial or ocular surgery
- Patients with a history of laparotomy
- Individuals with bullous lung disease
- Patients with uncontrolled chronic obstructive lung disease
- Patients with hemodynamic instability or decompensated heart failure
- Patients who require conversion to an open surgical procedure for any reason
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 특수 증상
- 할당: 무작위화되지 않음
- 중재 모델: 병렬 할당
- 마스킹: 하나의
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
다른: Group O
Obese patients with BMI ≥ 30 kg/m² |
Following intubation and desufflation, an incremental alveolar recruitment maneuver (ARM) will be performed, in which the driving pressure is kept constant while the PEEP value is increased in a stepwise manner. The ARM will be performed in pressure control mode, maintaining pressure at a steady driving pressure with increments in PEEP until a peak pressure is achieved (35-40 cmH2) with a preestablished maximum PEEP. This will be maintained long enough to reopen the alveoli (5---10 breaths), and then pressure is reduced in a stepwise manner until the ideal PEEP is achieved (this being the PEEP level that produces the best Cdyn at the lowest driving pressure for a particular tidal volume setting) ONSD will be measured at a standard level of 3 mm behind using a lineer ultrasound transducer. The measurements will be performed by an anesthesiologist experienced in ONSD measurement. The eyes will be covered with drapes; subsequently, using an ultrasound-compatible gel, measurements of both of the patient's eyes will be taken in a transverse and a sagittal plane. The mean of these measurements will then be calculated to determine the ONSD value. |
|
다른: Group N
Non-obese patients |
Following intubation and desufflation, an incremental alveolar recruitment maneuver (ARM) will be performed, in which the driving pressure is kept constant while the PEEP value is increased in a stepwise manner. The ARM will be performed in pressure control mode, maintaining pressure at a steady driving pressure with increments in PEEP until a peak pressure is achieved (35-40 cmH2) with a preestablished maximum PEEP. This will be maintained long enough to reopen the alveoli (5---10 breaths), and then pressure is reduced in a stepwise manner until the ideal PEEP is achieved (this being the PEEP level that produces the best Cdyn at the lowest driving pressure for a particular tidal volume setting) ONSD will be measured at a standard level of 3 mm behind using a lineer ultrasound transducer. The measurements will be performed by an anesthesiologist experienced in ONSD measurement. The eyes will be covered with drapes; subsequently, using an ultrasound-compatible gel, measurements of both of the patient's eyes will be taken in a transverse and a sagittal plane. The mean of these measurements will then be calculated to determine the ONSD value. |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Optic nerve sheath diameter (ONSD)
기간: Perioperative/Periprocedural (t0-after anesthesia induction and entubation)
|
Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound |
Perioperative/Periprocedural (t0-after anesthesia induction and entubation)
|
|
Optic nerve sheath diameter (ONSD)
기간: Perioperative/Periprocedural (t1- following the recruitment maneuver and the adjustment of the individualized PEEP value)
|
Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound |
Perioperative/Periprocedural (t1- following the recruitment maneuver and the adjustment of the individualized PEEP value)
|
|
Optic nerve sheath diameter (ONSD)
기간: Perioperative/Periprocedural (t2- at the 30th minute of pneumoperitoneum)
|
Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound |
Perioperative/Periprocedural (t2- at the 30th minute of pneumoperitoneum)
|
|
Optic nerve sheath diameter (ONSD)
기간: Perioperative/Periprocedural (t3 - after desufflation)
|
Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound |
Perioperative/Periprocedural (t3 - after desufflation)
|
|
Optic nerve sheath diameter (ONSD)
기간: Perioperative/Periprocedural (t4- following a subsequent recruitment maneuver)
|
Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound |
Perioperative/Periprocedural (t4- following a subsequent recruitment maneuver)
|
|
Optic nerve sheath diameter (ONSD)
기간: Perioperative/Periprocedural (t5- at the 30th minute in the recovery room)
|
Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound |
Perioperative/Periprocedural (t5- at the 30th minute in the recovery room)
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
MAP
기간: Perioperative (Noninvasive mean arterial pressure will be recorded at the times when ONSD measurement is performed)
|
Noninvasive mean arterial pressure (mmHg) |
Perioperative (Noninvasive mean arterial pressure will be recorded at the times when ONSD measurement is performed)
|
|
HR
기간: Perioperative (Heart rate will be recorded at the times when ONSD measurement is performed)
|
Heart rate (beat/min) |
Perioperative (Heart rate will be recorded at the times when ONSD measurement is performed)
|
|
etCO2
기간: Perioperative (End-tidal carbon dioxide levels will be recorded at the times when ONSD measurement is performed)
|
End-tidal carbon dioxide levels (mmHg) |
Perioperative (End-tidal carbon dioxide levels will be recorded at the times when ONSD measurement is performed)
|
기타 결과 측정
기타 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Airway pressures during mechanical ventilation
기간: Perioperative (Ppeak, Pplato, Driving pressure (∆P), PEEP levels will be recorded at the times when ONSD measurement is performed)
|
Ppeak, Pplato, Driving pressure (∆P), PEEP levels (cmH20) will be recorded from the sama ventilation monitor screen |
Perioperative (Ppeak, Pplato, Driving pressure (∆P), PEEP levels will be recorded at the times when ONSD measurement is performed)
|
|
Postoperative complications
기간: PONV will be questioned at the 24th hours
|
Postoperative nause and vomiting (PONV) |
PONV will be questioned at the 24th hours
|
|
Postoperative complications
기간: Headache will be questioned at the 24th hours
|
Headache |
Headache will be questioned at the 24th hours
|
|
Postoperative complications
기간: Visual disturbance will be questioned at the 24th hours
|
Visual disturbance |
Visual disturbance will be questioned at the 24th hours
|
공동 작업자 및 조사자
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
기타 연구 ID 번호
- E-25403353-050.04-260108454
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .